title: Hypothyroidism associated with nivolumab treatment of unresectable malignant melanoma.
authors.affiliation: Department of Dermatology, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 3-18-22 Honkomagoame, Bunkyo-ku, Tokyo, 113-8677, Tokyo, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Imafuku
authors.affiliation: Department of Dermatology, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 3-18-22 Honkomagoame, Bunkyo-ku, Tokyo, 113-8677, Tokyo, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Yoshino
authors.affiliation: Department of Dermatology, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 3-18-22 Honkomagoame, Bunkyo-ku, Tokyo, 113-8677, Tokyo, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Yamaguchi
authors.affiliation: Department of Dermatology, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 3-18-22 Honkomagoame, Bunkyo-ku, Tokyo, 113-8677, Tokyo, Japan.
authors.forename: S
authors.initials: S
authors.lastname: Tsuboi
authors.affiliation: Department of Dermatology, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 3-18-22 Honkomagoame, Bunkyo-ku, Tokyo, 113-8677, Tokyo, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Ohara
authors.affiliation: Department of Dermatology, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
authors.forename: H
authors.initials: H
authors.lastname: Hata
mesh_terms: D000368:Aged; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D006801:Humans; D007037:Hypothyroidism / Q000139:chemically induced*; D008297:Male; D008545:Melanoma / Q000188:drug therapy*; D000077594:Nivolumab; D012004:Rectal Neoplasms / Q000188:drug therapy*; D013963:Thyroid Hormones / Q000097:blood
chemical_list: D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D013963:Thyroid Hormones; D000077594:Nivolumab